Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 2:07 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1825–1848 of 18,255 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Controlled Group Clear all

Conditions: Disc Degeneration
Interventions: MSC Treatment group 1 (low dose), MSC Treatment group 2 (high dose), Healthy Control (no treatment); Drug · Other
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years to 80 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Sprain, Strain
Interventions: Ketoprofen Topical Patch 20%; Drug
Lead sponsor: Alkemira SA; Industry
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Fistula Stenosis
Interventions: Paclitaxel, Standard Therapy; Drug · Procedure
Lead sponsor: Englewood Hospital and Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Englewood, New Jersey

Conditions: Age-related Macular Degeneration
Interventions: MT-0814, Placebo; Drug
Lead sponsor: Senju Pharmaceutical Co., Ltd.; Industry
Eligibility: 50 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 13
States / cities: Peoria, Arizona • Phoenix, Arizona • Pasadena, California + 10 more

Conditions: Behavior and Behavior Mechanisms
Interventions: Peer Mentoring, e-Communication with mentor; Behavioral
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 14 Years to 23 Years
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Leg Ulcer
Interventions: CO2RE® (Syneron Candela Corp, Wayland, MA), Sham laser treatment; Device · Other
Lead sponsor: St. Louis University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 2
States / cities: St Louis, Missouri

Conditions: Treatment Outcome
Interventions: Vortioxetine, Escitalopram, Placebo; Drug
Lead sponsor: Takeda; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 447 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 53
States / cities: Birmingham, Alabama • Tucson, Arizona • Anaheim, California + 50 more

Conditions: Cognitive Function, Preclinical, Chronic Kidney Diseases, Older Adults
Interventions: Partially supervised home-based walking exercise, Control; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 60 Years to 80 Years
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Prediabetes, Overweight
Interventions: Stress Management, Diet, Exercise, Culinary education; Behavioral
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older · Female only
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 1
States / cities: East Cleveland, Ohio

Conditions: Hidradenitis Suppurativa
Interventions: Bimekizumab, Placebo; Drug · Other
Lead sponsor: UCB Biopharma SRL; Industry
Eligibility: 18 Years and older
Enrollment: 509 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 24
States / cities: Fountain Valley, California • Thousand Oaks, California • Miami, Florida + 21 more

Conditions: Papulopustular Rosacea
Interventions: Azelaic acid foam, 15% (BAY39-6251), Vehicle foam; Drug
Lead sponsor: LEO Pharma; Industry
Eligibility: 18 Years and older
Enrollment: 961 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 49
States / cities: Birmingham, Alabama • Fremont, California • Los Angeles, California + 41 more

Conditions: Immune Response, Inflammation
Interventions: Almond group, Control Group; Dietary Supplement
Lead sponsor: Loma Linda University; Other
Eligibility: 40 Years to 70 Years
Enrollment: 61 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Teen Pregnancy
Interventions: My Future Self; Behavioral
Lead sponsor: Children's Hospital Los Angeles; Other
Eligibility: 16 Years to 19 Years
Enrollment: 704 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Papulopustular Rosacea (PPR)
Interventions: CD5024, Azelaic acid 15% Gel; Drug
Lead sponsor: Galderma R&D; Industry
Eligibility: 18 Years and older
Enrollment: 683 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 40
States / cities: Birmingham, Alabama • Rogers, Arkansas • Los Angeles, California + 36 more

Conditions: Heavy Menstrual Bleeding, Uterine Fibroid
Interventions: Relugolix, Estradiol/norethindrone acetate, Relugolix placebo, Estradiol/norethindrone acetate placebo; Drug
Lead sponsor: Myovant Sciences GmbH; Industry
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 382 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 89
States / cities: Birmingham, Alabama • Mesa, Arizona • Tucson, Arizona + 78 more

Conditions: Relapsing-remitting Multiple Sclerosis, Secondary-progressive Multiple Sclerosis, Primary-progressive Multiple Sclerosis
Interventions: estriol, Placebo, Norethindrone, Progestin Placebo; Drug · Other
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2022
U.S. locations: 4
States / cities: Los Angeles, California • Aurora, Colorado • Albuquerque, New Mexico + 1 more

Conditions: Molluscum Contagiosum
Interventions: SB206 12%, Placebo; Drug
Lead sponsor: Novan, Inc.; Industry
Eligibility: 6 Months and older
Enrollment: 352 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 35
States / cities: Mobile, Alabama • Glendale, Arizona • Little Rock, Arkansas + 32 more

Conditions: Obesity, Adolescent, Healthy Nutrition, Sedentary Behavior, Drug Abuse
Interventions: Wakaya: Rising Up for Choctaw Youth Curriculum; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 12 Years to 19 Years
Enrollment: 176 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: Durant, Oklahoma • Seattle, Washington

Conditions: Multiple Sclerosis
Interventions: Fampridine-SR, Placebo; Drug
Lead sponsor: Acorda Therapeutics; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 36
States / cities: Phoenix, Arizona • Fayetteville, Arkansas • Berkeley, California + 31 more

Conditions: Obesity, Energy Balance, Appetite, Metabolism, Insulin Sensitivity
Interventions: Aerobic exercise, Newsletter; Behavioral
Lead sponsor: Children's Mercy Hospital Kansas City; Other
Eligibility: 14 Years to 17 Years
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Alcohol Drinking, Alcohol Drinking Related Problems
Interventions: Retrieval-extinction, Alcohol-related cues, Soft-drink related cues; Behavioral
Lead sponsor: National Institute on Drug Abuse (NIDA); NIH
Eligibility: 21 Years to 65 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Heart Failure
Interventions: REGN5381, Placebo; Drug
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 4
States / cities: Phoenix, Arizona • Torrance, California • Miami, Florida + 1 more

Conditions: Development
Interventions: Low Sodium Group; Other
Lead sponsor: Monell Chemical Senses Center; Other
Eligibility: 7 Years to 65 Years
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Diabetes Mellitus, Type 2
Interventions: iDSMES, Standard of Care; Other
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 13 Years to 84 Years
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Galveston, Texas

Search by objective public record fields.

Mesenchymal Stem Cells for Lumbar Degenerative Disc Disease

Efficacy and Safety of Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Ankle Sprain or Strain

Paclitaxel for the Treatment of Upper-Extremity Arteriovenous Access Fistula Stenosis

A Study to Assess the Safety, Tolerability and Effectiveness of MT-0814 for the Treatment of Age-related Macular Degeneration

Peers for Promoting Adolescent Transplant Health

Evaluating the Safety and Efficacy of Fractionated Carbon Dioxide Therapy in Postoperative Lower Extremity Wound Healing

Vortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual Dysfunction

Exercise Training and Cognitive Function in Kidney Disease

FRESH Study (Fitness, Relaxation and Eating to Stay Healthy)

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa

Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea

Effect of Almonds on Immune Strength and Response to Flu Vaccination in Overweight Older Men and Postmenopausal Women: A Randomized Controlled Study

Evaluation of My Future Self, an New Teen Pregnancy Prevention Group Intervention for Youth in Non-traditional Settings

Phase 3 Papulopustular Rosacea Study

LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition

A Phase 3 Randomized Parallel Group Study Comparing the Efficacy & Safety of SB206 & Vehicle Gel in the Treatment of MC (B-SIMPLE1)

Wakaya: Rising Up for Choctaw Youth Health

Study of Fampridine-SR Tablets in Multiple Sclerosis Patients

Activity, Adiposity, and Appetite in Adolescents 2 Intervention

Effects of a New Behavioral Intervention on Alcohol Craving and Drinking

REGN5381 in Adult Participants With Heart Failure With Reduced Ejection Fraction

Shifting Salty Taste Preferences in Children

A Comprehensive Community Approach for Diabetes Prevention and Care for a Vulnerable Population in Galveston